A股異動丨京山輕機漲停 美國新規限制人工智能軟件出口
格隆匯1月6日丨京山輕機(000821.SZ)漲停,報7.08元,總市值38億元。

據外媒,針對中國等國家,特朗普政府在上週五采取了措施來限制人工智能軟件的出口,新規將於本週一生效。國內人工智能概念股受關注。京山輕機目前已形成以智能裝備製造為主、汽車零部件鑄造為輔的發展格局。公司目前提供的產品和服務更加豐富,在產線自動化和智能物流、智能倉儲系統的基礎上,智能工廠、工廠自動化改造等業務全面鋪開;公司已經建立了從人工智能算法開發、視覺識別模塊、精密部件、產線自動化、物流倉儲自動化、智能工廠等多層次、多領域的智能裝備製造業務體系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.